Lifestar Pharma

What Lifestar Pharma does

Lifestar Pharma LLC is a U.S.-based generic pharmaceutical company founded in 2016 as a wholly owned subsidiary of Mankind Pharma, India's third-largest pharmaceutical company. The company is headquartered in Mahwah, New Jersey, and specializes in developing, manufacturing, and commercializing high-barrier generic medicines across four primary dosage forms: ophthalmics, injectables, inhalation solutions, and oral solids. Its product portfolio includes 50+ generics launched in the U.S. market, with notable products including Bimatoprost Ophthalmic Solution (first generic to LUMIGAN®), Naloxone Hydrochloride Injection, Ephedrine Sulfate Injection, Arformoterol Tartrate Inhalation Solution, and Atorvastatin Calcium Tablets. Manufacturing is anchored at Mankind Pharma's USFDA-approved Unit 3 in India, with proprietary vertical integration into API (Active Pharmaceutical Ingredient) manufacturing — a meaningful cost and supply-chain advantage.

The company operates a B2B go-to-market model, distributing generics through direct sales to hospitals, specialty pharmacies, and wholesalers across the United States. Its commercialization infrastructure, led by a dedicated SVP of Commercialization, supports sales operations, distribution partnerships, and customer engagement. Beyond direct commercialization, Lifestar pursues co-development, in-licensing, ANDA/505(b)(2)/NDA acquisition, and marketing & distribution arrangements for ANDA and Authorized Generic products, creating an additional revenue and portfolio-growth vector. R&D operations span 4 R&D centers with 400+ scientists dedicated to small-molecule and biologics product development, with expertise in formulation development and API R&D. The company is led by CEO Dr. Vijay Soni, who has been with the company since inception, supported by an executive team with backgrounds at Glenmark, Dr. Reddy's, Ranbaxy, Accord Healthcare, Johnson & Johnson, and Pfizer. Quality and regulatory systems are aligned to USFDA, WHO-GMP, and 21 CFR Part 11 standards.

Name

Lifestar Pharma

Legal name

Lifestar Pharma LLC

Website

https://lifestarpharma.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Lifestar Pharma LLC is a U.S. subsidiary of Mankind Pharma that develops and commercializes high-barrier generic medicines across ophthalmics, injectables, inhalation solutions, and oral solids. The company serves U.S. hospitals, specialty pharmacies, and wholesalers, with 50+ generics launched and USFDA-approved manufacturing operations.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)

akta.pro secondary industries

Oral Solid Dose (OSD) Generics (HLAIABAD), Sterile Injectable Generics (HLAIABAC), Generic ANDA/Regulatory Affairs & Submissions (HLAIABAJ), Generic APIs & Intermediates (Active Ingredients) (HLAIABAG)

Keywords

• Generic pharmaceuticals
• High-barrier generics
• Ophthalmic solutions
• Injectable medications
• Inhalation solutions

Headquarters

HQ city

Mahwah

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Generic Pharmaceutical Sales: Revenue generated from manufacturing and selling high-barrier generic pharmaceuticals across ophthalmics, injectables, inhalation solutions, and oral solids to healthcare providers including hospitals, specialty pharmacies, and wholesalers in the US market.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels1 record

Core offering

Lifestar Pharma LLC develops, manufactures, and commercializes high-barrier generic pharmaceutical products across four primary dosage forms: ophthalmics, injectables, inhalation solutions, and oral solids. The company focuses on complex generic formulations requiring specialized expertise and has successfully launched 50+ generics in the U.S. market. Lifestar operates USFDA-approved facilities for both finished dosage manufacturing and API manufacturing, supplying US hospitals, specialty pharmacies, and wholesalers.

Product overview

Lifestar Pharma is a U.S.-based pharmaceutical company and subsidiary of Mankind Pharma that develops and commercializes high-barrier generic medicines across four primary dosage forms: Ophthalmics (including Atropine Sulfate, Timolol Maleate, Phenylephrine Hydrochloride, and Bimatoprost solutions), Injectables (Ephedrine Sulfate, Naloxone Hydrochloride, Verapamil Hydrochloride), Inhalation Solutions (Arformoterol Tartrate, Formoterol Fumarate), and Oral Solids (Alosetron, Nitroglycerin Sublingual, Omega-3 Acid Ethyl Esters Capsules, Acetazolamide, Amitriptyline Hydrochloride, Atorvastatin Calcium, Baclofen, Bumetanide, Capecitabine, Chlorthalidone, Clomipramine Hydrochloride). The portfolio includes 50+ generics launched with USFDA-approved facilities, focusing on complex formulations that serve hospitals, specialty pharmacies, and wholesalers across the United States.

Differentiator

Problem solved

Functional benefit

Products and services

• Atropine Sulfate Ophthalmic Solution

Quantifiable outcome

• 50+ generics launched successfully in US market
• +1 more outcomes

Named customers3 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• Organizations seeking Co-Development and In-Licensing partnershipscoreStrategic or Co-development PartnerLifestar partners with organizations leveraging their expertise in development of complex multisource products. The company brings strong Product Selection, Technical, IP, Regulatory and Financial expertise with a commitment to partnership for co-development of high-barrier generics.
• ANDA / 505(b)(2) / NDA SellerscoreStrategic or Co-development PartnerLifestar actively pursues opportunities to acquire ANDAs, 505(b)(2)s and NDAs that are strategically aligned with their business plan, enabling expansion of their generic pharmaceutical portfolio.
• Marketing & Distribution PartnerscoreChannel Partner/ Reseller/ DistributorLifestar has built strong commercialization capabilities and is positioned to take on Marketing, Selling and Distribution arrangements for ANDA and Authorized Generic products, expanding their reach in the US market.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Sun Pharmaceutical Industries: India-headquartered global generic pharmaceutical manufacturer with a large US specialty/generics business (including Taro Pharmaceutical). Closely matches Lifestar's profile: India-based parent, USFDA-approved facilities, complex generics portfolio, and B2B distribution to US wholesalers and hospitals.
• Aurobindo Pharma: India-based generic pharmaceutical manufacturer with substantial US operations (AuroMedics, Aurolife) focused on injectables, oral solids, and high-barrier formulations. Directly comparable to Lifestar in business model: India-rooted API+finished-dose integration targeting the US generic market.
• Endo International: US-focused specialty and generic pharmaceutical company with strong presence in sterile injectables, ophthalmics, and complex generics via Par Pharmaceutical. Directly comparable as a US generics specialist emphasizing high-barrier, difficult-to-formulate products.
• Dr. Reddy's Laboratories: India-based global generics manufacturer with strong US presence across sterile injectables, orals, and complex generics. Direct peer given shared India origin, USFDA-approved facilities, complex-generics focus, and personal ties (Lifestar's CEO previously worked at Dr. Reddy's USA).
• Hikma Pharmaceuticals: Jordan-headquartered generic and specialty pharmaceutical company with significant US operations (Hikma Pharmaceuticals USA) focused on sterile injectables and oral generics. Closely matches Lifestar in target product categories and US B2B distribution model.
• Glenmark Pharmaceuticals: India-headquartered generics and specialty pharma company with US commercial operations and a portfolio of complex generics, dermatology, and respiratory products. Direct peer reflecting shared India base, USFDA facilities, and ties via Lifestar CEO's prior experience at Glenmark.
• Lannett Company: US-based generic pharmaceutical manufacturer with portfolio spanning oral solids, injectables, and topical generics distributed through wholesalers and pharmacies. Smaller US generics specialist comparable in scale and business model to Lifestar.

Broad incumbents

• Sandoz: Novartis's generic pharmaceuticals division with a leading global generics portfolio spanning complex generics, biosimilars, and injectables. Broad incumbent with deep USFDA manufacturing footprint and overlapping product categories in ophthalmics and sterile injectables.
• Viatris: Global generics and biosimilars company (formed via Mylan-Upjohn merger) with one of the largest US generic portfolios including injectables, ophthalmics, and orals. Broad incumbent with overlapping portfolio and well-established US commercialization infrastructure.
• Teva Pharmaceutical Industries: World's largest generic pharmaceutical manufacturer with extensive US portfolio across sterile injectables, orals, and specialty. Broad incumbent operating at much larger scale than Lifestar but overlapping on virtually every complex generic category Lifestar competes in.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/lifestar-pharma-private-limited

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lifestar Pharma